Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Cash & Equivalents: 2021-2023

Historic Cash & Equivalents for Zymeworks (ZYME) over the last 1 years, with Sep 2023 value amounting to $94.3 million.

  • Zymeworks' Cash & Equivalents fell 1.82% to $94.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $94.3 million, marking a year-over-year decrease of 1.82%. This contributed to the annual value of $400.9 million for FY2022, which is 98.60% up from last year.
  • According to the latest figures from Q3 2023, Zymeworks' Cash & Equivalents is $94.3 million, which was down 33.62% from $142.1 million recorded in Q2 2023.
  • Zymeworks' Cash & Equivalents' 5-year high stood at $400.9 million during Q4 2022, with a 5-year trough of $94.3 million in Q3 2023.
  • For the 3-year period, Zymeworks' Cash & Equivalents averaged around $186.1 million, with its median value being $161.8 million (2023).
  • Per our database at Business Quant, Zymeworks' Cash & Equivalents spiked by 98.60% in 2022 and then declined by 1.82% in 2023.
  • Over the past 3 years, Zymeworks' Cash & Equivalents (Quarterly) stood at $201.9 million in 2021, then surged by 98.60% to $400.9 million in 2022, then fell by 1.82% to $94.3 million in 2023.
  • Its last three reported values are $94.3 million in Q3 2023, $142.1 million for Q2 2023, and $181.6 million during Q1 2023.